Stephen Manobianco, MBA – Managing Director
Senior-level professional experienced working with public and private companies at the executive level.
Highly analytical decision-maker with extensive experience with domestic and international start-ups, turn-around, and operating companies, along with proven history of increasing productivity and accelerating revenue growth.
Seasoned executive with in-depth understanding of emerging genomic and healthcare related technologies and their commercial applications. International business expertise including North America, Europe, Israel, China and Japan.
Vidal de la Cruz, PhD – Scientific Director
Biopharma scientist and executive with 20+ years’ experience in preclinical discovery research & product development, technology & asset scouting and assessment, management, and business development & licensing with start-up, mid-size and international biotechnology/pharmaceutical companies.
A Ph.D. scientist with scientific achievements that include key discovery research and tools (e.g., inventor of Peptide Phage Display, key technology leading to the 2018 Nobel Prize in Chemistry awarded to Dr. George Smith; first use of recombinant BCG as a vaccine vehicle). Broad scientific expertise including cellular immunotherapies (CAR-T, CAR-CIK), monoclonal antibodies, gene therapy, viral and non-viral gene delivery, small molecule drugs, vaccines, molecular biology and immunology of infectious disease agents (malaria, bacterial, fungal & viral infections), oncology, autoimmune diseases, inflammation and allergy, women’s health, animal health and nutrition, genomics, in vitro and in vivo assays, and animal model development.
Vidal leads our Scientific Due Diligence and Strategy Practice.
Charles Ziegler, CMA MBA CSCA – Financial Performance Director
Seasoned senior level financial executive with experience in R&D and commercialization of medical devices and pharmaceuticals. Domestic and international experience on due diligence, operations, strategic planning, budgeting and forecasting, ERP/CRM, process improvement and sales territories and commission plans.
Charles leads our Due Diligence and Financial Performance Improvement Practice.
Claudia Li, MS – Marketing Performance and Execution Director
High-performance marketing manager with extensive experience in digital marketing and marketing communication specializing in biotechnology companies. Skilled at managing and operating in a wide range of marketing channels and platforms. Claudia provides clients with strategic and tactical support to create marketing collateral, lead generation programs, email campaigns, social media optimization, search engine marketing, marketing communication, sales support, product management, etc.
Claudia leads our Marketing Execution and Performance Improvement Practice